Cargando…
Systemic Treatment with Pioglitazone Reverses Vision Loss in Preclinical Glaucoma Models
Neuroinflammation significantly contributes to the pathophysiology of several neurodegenerative diseases. This is also the case in glaucoma and may be a reason why many patients suffer from progressive vision loss despite maximal reduction in intraocular pressure. Pioglitazone is an agonist of the p...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961625/ https://www.ncbi.nlm.nih.gov/pubmed/35204782 http://dx.doi.org/10.3390/biom12020281 |